Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 20,000 shares at $121.65 ($2.4M) on 2026-07-06, disclosed to the SEC on 2026-07-08.
Scheduled sale ($2.4M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.65 | 12,134 | $1.5M | 60.4% |
| 2 | $122.34 | 4,181 | $512K | 20.9% |
| 3 | $123.74 | 1,975 | $244K | 10.0% |
| 4 | $124.79 | 1,710 | $213K | 8.7% |
| Total | $122.27 avg | 20,000 | $2.4M | 100% |
| Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |
| MIRM | SELL | 2026-02-03 | $941K | — | Filing → |